Full text is available at the source.
Abstract
Obesity-related heart failure with preserved ejection fraction is associated with significant symptom burden and impaired mobility.
- Patients with this condition experience reduced health status.
- Incretin-based therapies and sodium-glucose cotransporter 2 inhibitors have not been directly compared.
- Lack of comparative evidence limits understanding of treatment effectiveness.
Simplified